Case based approach to Heart Failure Management

Case based approach to Heart Failure Management


2 Hours

English Site

Recorded Webinar


Course Overview


Cardiological Society of India – Rajasthan Branch welcomes to the recorded session on Scientific Program, topic "Case based approach to Heart Failure Management ". 


Two sessions  
Session 1: Dr Rajeev Gupta 
Case based approach to Heart Failure Management-  
Topic 1: Slow and steady wins the race – stepwise approach 
Case 1:  
●History and past symptoms  
●ACCF/ AHA and NYHA classification explained in detail 
●Example papers to explain prognosis and with respect to EF/HF 
●Initial Management of the Patient  
●Major concerns and further management  
●Stepwise therapies as per guidelines 
●Foundational therapy (basic pharmacological therapy) with ACEi/ARB ,beta blockers 
and MRA  
●Reduction in risk of HF and long-term outcomes 
●Trails stating benefit of different drugs 
●HFrEF therapy guidelines in AHA/ACC/HFSA focussed on ESE guidelines in stepwise 
●Management using right drug at right level/step 
●Canadian guidelines 
●Use of ACE inhibitors and beta blockers reduce mortality   
●Add drugs only if patient is still symptomatic even after maximum tolerated dose of 
conventional therapy 
●Polypharmacy should be avoided 
●In case of adverse reaction discontinue drugs  
●Use of optimal doses in clinal trails, combination therapy and other studies  
●Pharmacological therapy - newer drugs available 
●Criteria for PARADIGM-HF  
●Trail to study effect of DAPAGLIFLOZIN 
●AF trail – digoxin shows positive effects  
●Discussion of never line of drugs (SGLT2 and ARNI) 

Session 2: Dr J C Mohan  
Management approach to a patient with HFrEF –  
Topic 2: Hit early Hit Hard (SGLT2i should be used early) 
Case 2:  
●Past History and symptoms  
●Initial treatment given  
●Relevant data regarding case  
●Prevalence of CKD (corelation with eGFR)  
●Renal compartment syndrome, abdominal compartment syndrome, reduced forward output 
syndrome and pre-existing KD  
●The patient has High mortality, recurrent hospitalisations and poor quality of life with HF  
●Maggic score – determine prognosis and mortality 
●Risk therapy paradox explained  
●Explanation of guideline mandated therapy ( Anti RASS , BB ,MRA,SGLT2-i, devices ) 
●Failure rate of therapy is 60% 
●Impactful therapy with other drugs and other approaches 
●Comprehensive therapy vs conventional therapy 
●Benefits of adding newer drugs early during therapy 
●Benefit of Lisinopril , ACE , ARNI , DAPA HF and SGLT2i early with evidence 
●Principles of optimising care in HF  
●Best three drug combination in this case Explained  
●Recommended dose according to the Asian heart failure registry 
●Explanation of use of ARNI in the patient 

Session 3: Dr Ashwini Kumar Sharma  
Recurrent SFC Thrombosis: PTA Under Peripheral IVUF guidance  
Case 3:  
●Case presentation  
●Explanation of procedures done during the course of hospitalization with graphic 
●CDT is effective in ALI 
●Peripheral IVUS is helpful in evaluating the etiology of TVF and aids to angiography in 
subsequent management. 

Session 4: Dr Rajeev Sharma  
Basic EP study 
●Baseline and Tachycardia ECG was explained  
●Description of Anatomy  
●Description of placement of catheter  
●Reading and diagnosing ECG 

​​​​​We wish you a great learning experience and thank our sponsors Astra Zeneca to make this program possible. 


Coming session Starts Sep 24, 2020
Ends Dec 24, 2020